----
MaxCyte (MXCT)
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's produc...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
MaxCyte Analyst Rating
View moreForecast & Rating
Oct 15, 2026Price forecast
$4.11181.34%
Forecast & RatingStrong buy
6analysts
- Strong buy83.33%
- Buy0.00%
- Hold16.67%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 5
- Buy
- 0
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
